辛洪亮

发布时间:2020-07-01浏览次数:12130

 

辛洪亮,男,博士教授,博士生导师,江苏省杰出青年基金和江苏省优秀青年基金获得者,现任澳门威斯人0168药剂学系副主任入选江苏省333高层次人才培养工程(第二层次)江苏省“青蓝工程” 中青年学术带头人,江苏省“六大人才高峰” 高层次人才,江苏省“双创计划”(科技副总),南京医科大学优秀中青年学科(学术)带头人。目前兼任中国药学会药剂学专业委员会青年委员,中国中药协会新技术专委会副秘书长,江苏省药剂专业委员会委员,Asian Journal of Pharmaceutical SciencesAJPS)杂志青年编委,国家自然科学基金通讯评审专家,江苏省、广东省、上海市等科技评审专家,Advanced Materials, Science Advances, ACS Nano, Advanced Functional Materials, Journal of Controlled Release等杂志审稿专家。

指导全国医药院校药学/中药学大学生创新创业大赛特等奖,全国药苑论坛“创新成果二等奖”,全国药学/中药实验技能大赛特等奖和一等奖等。曾被评为南京医科大学优秀本科生导师,南京医科大学研究生“十佳学术之星”指导老师等称号。

近年来,主要围绕脑胶质瘤脑卒中ADPD等脑部重大疾病,聚焦中枢神经系统智能化药物递送策略及其载体设计研究,主持国家自然科学基金面上项目、江苏省杰青、优青等各类纵向课题及横向课题十余项,在ACS Nano, Biomaterials, Journal of Controlled Release等国际著名专业期刊发表高水平论文三十余篇,总引用3800余次,申请国家发明专利15项,已授权发明专利8项,专利转让3项。

招生方向:

1.新型药物递送系统

2.药学

联系方式:

E-mailxhl@njmu.edu.cn

代表性论文

1. Shanbo Sun#, Wei Lv#, Shengnan Li, Qi Zhang, Weichong He, Zhiyi Min, Chuanhui Teng, Yuqin Chen, Linfeng Liu, Jiaqing Yin, Baoli Zhu, Ming Xu*, Dongwei Dai*, Hongliang Xin* . Smart liposomal nanocarrier enhanced the treatment of ischemic stroke through neutrophil extracellular traps and cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes (cGAS-STING) pathway inhibition of ischemic penumbra. ACS Nano 2023, 17(18), 17845–17857

2. Lu Ye#, Wei Lv#, Weichong He, Shengnan Li, Zhiyi Min, Le Gong, Qi Zhang, Chuanhui Teng, Shanbo Sun, Lingyan Lv, Yi Guo*, Hongliang Xin*. Reduced malignant glioblastoma recurrence post-resection through the anti-CD47 antibody and Temozolomide co-embedded in-situ hydrogel system. Journal of Controlled Release 2023, 359: 224–233.

3. Xiaoqi Wang#, Lu Ye#, Weichong He, Chuanhui Teng, Shanbo Sun, Hongdan Lu, Shengnan Li, Lingyan Lv, Xiang Cao, Haoyuan Yin, Wei Lv*, Hongliang Xin*. In situ targeting nanoparticles-hydrogel hybrid system for combined chemo-immunotherapy of glioma. Journal of Controlled Release 2022, 345: 786-797.

4. Hongdan Lu#, Shengnan Li#, Dongwei Dai#, Qi Zhang, Zhiyi Min, Chuanzhou Yang, Shanbo Sun, Lu Ye, Chuanhui Teng, Xiang Cao, Haoyuan Yin, Lingyan Lv, Wei Lv*, Hongliang Xin*. Enhanced Treatment of Cerebral Ischemia-reperfusion Injury by Intelligent Nanocarriers through the Regulation of Neurovascular Units. Acta Biomaterialia 2022, 147314-326.

5. Xianpei Xu#, Xiaoqi Wang#, Haoyuan Yin, Xiang Cao, Quanyin Hu, Wei Lv, Qunwei Xu, Zhen Gu*, Hongliang Xin*. Sequentially Site-Specific Delivery of Thrombolytics and Neuroprotectant for Enhanced Treatment of Ischemic Stroke. ACS Nano 2019 13(8):8577-8588. 


Baidu
sogou